Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,004 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of LINE-Assisted Provision of Information about Human Papillomavirus and Cervical Cancer Prevention on HPV Vaccine Intention: A Randomized Controlled Trial.
Ota Y, Nomura K, Fujita N, Suzuki T, Kamatsuka M, Sakata N, Nagashima K, Hirayama J, Fujita N, Shiga K, Oyama N, Terada Y. Ota Y, et al. Among authors: nagashima k. Vaccines (Basel). 2022 Nov 24;10(12):2005. doi: 10.3390/vaccines10122005. Vaccines (Basel). 2022. PMID: 36560414 Free PMC article.
Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer.
Narita S, Nomura K, Hatakeyama S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Ohyama C, Arai Y, Nagashima K, Habuchi T. Narita S, et al. Among authors: nagashima k. Sci Rep. 2019 Aug 19;9(1):12071. doi: 10.1038/s41598-019-48600-8. Sci Rep. 2019. PMID: 31427687 Free PMC article.
Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy.
Narita S, Nomura K, Hatakeyama S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Ohyama C, Arai Y, Nagashima K, Habuchi T. Narita S, et al. Among authors: nagashima k. Cancer Med. 2019 Nov;8(15):6566-6577. doi: 10.1002/cam4.2502. Epub 2019 Sep 11. Cancer Med. 2019. PMID: 31508900 Free PMC article.
Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination.
Uwamino Y, Nagashima K, Yoshifuji A, Suga S, Nagao M, Fujisawa T, Ryuzaki M, Takemoto Y, Namkoong H, Wakui M, Matsushita H, Hasegawa N, Sato Y, Murata M. Uwamino Y, et al. Among authors: nagashima k. NPJ Vaccines. 2023 Mar 6;8(1):33. doi: 10.1038/s41541-023-00626-w. NPJ Vaccines. 2023. PMID: 36878929 Free PMC article.
2,004 results